Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.990
-0.140 (-4.47%)
At close: Mar 24, 2026, 4:00 PM EDT
3.120
+0.130 (4.35%)
After-hours: Mar 24, 2026, 5:44 PM EDT

Xenetic Biosciences Revenue

In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth. Xenetic Biosciences had revenue of $766.30K in the quarter ending December 31, 2025, with 18.11% growth.

Revenue (ttm)
$2.98M
Revenue Growth
+19.04%
P/S Ratio
2.41
Revenue / Employee
$1,488,206
Employees
2
Market Cap
6.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 201917.07K--
Dec 31, 2018---
Dec 31, 20177.59M4.59M152.83%
Dec 31, 20163.00M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20131.00M--
Sep 30, 2013---
Dec 31, 2012293.60K--
Aug 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition